ArticleAddiction (Abingdon, England)2017
The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California.
Article in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.
- Costs attributable to criminal justice involvement in injuries: a systematic review.Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention · 2023Pooled it
- Economic Evaluations of Pharmacologic Treatment for Opioid Use Disorder: A Systematic Literature Review.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021Pooled it
- Pharmacological Management of Opioid Use Disorder: A Systematic Review and Network Meta-Analysis: Prise en charge pharmacologique du trouble de l'usage des opiacés : revue systématique et méta-analyse en réseau.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026Review
- The Economic burden of opioid-related serious adverse events and undertreatment of acute pain in the United States.Frontiers in public health · 2026Review
- Allocative efficiency analysis of strategies to reduce overdose deaths among people with opioid use disorder and history of incarceration in Connecticut.BMC public health · 2025Article
- Understanding the financial barriers to treatment among individuals with opioid use disorder: a focus group study.Harm reduction journal · 2024Article
- Reducing overdose deaths among persons with opioid use disorder in connecticut.Harm reduction journal · 2024Article
- Allocation of federal funding to address the opioid overdose crisis in the criminal legal system.Journal of substance use and addiction treatment · 2023Article
- Cost-effectiveness of office-based buprenorphine treatment for opioid use disorder.Drug and alcohol dependence · 2023Article
- Patient motivators to use opioids for acute pain after emergency care.Frontiers in pain research (Lausanne, Switzerland) · 2023Article
- Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs.Addiction (Abingdon, England) · 2022Article
- Patient Pain Experiences and the Emergency Department Encounter: A Qualitative Analysis.Pain management nursing : official journal of the American Society of Pain Management Nurses · 2022Article
- Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder.International journal of environmental research and public health · 2022Article
- Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder.Drug and alcohol dependence · 2022Article
- How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value.The International journal on drug policy · 2021Article
- Cost-effectiveness of syringe service programs, medications for opioid use disorder, and combination programs in hepatitis C harm reduction among opioid injection drug users: a public payer perspective using a decision tree.Journal of managed care & specialty pharmacy · 2021Article
- Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan.Drug and alcohol dependence · 2020Article
- Cost-effectiveness of Direct Antiviral Agents for Hepatitis C Virus Infection and a Combined Intervention of Syringe Access and Medication-assisted Therapy for Opioid Use Disorders in an Injection Drug Use Population.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020Article
- The American Opioid Epidemic in Special Populations: Five Examples.NAM perspectives · 2020Review
- Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.Health affairs (Project Hope) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
Abstract
BACKGROUND AND
aimsTreatment for opioid use disorders (OUD) reduces the risk of mortality and infectious disease transmission; however, opportunities to quantify the potential economic benefits of associated decreases in drug-related crime are scarce. This paper aimed to estimate the costs of crime during and after periods of engagement in publicly funded treatment for OUD to compare total costs of crime during a hypothetical 6-month period following initiation of opioid agonist treatment (OAT) versus detoxification.
designRetrospective, administrative data-based cohort study with comprehensive information on drug treatment and criminal justice systems interactions.
settingPublicly funded drug treatment facilities in California, USA (2006-10).
participantsA total of 31 659 individuals admitted for the first time to treatment for OUD, and who were linked with criminal justice and mortality data, were followed during a median 2.3 years. Median age at first treatment admission was 32, 35.8% were women and 37.1% primarily used prescription opioids. MEASUREMENTS: Daily costs of crime (US$2014) were calculated from a societal perspective and were composed of the costs of policing, court, corrections and criminal victimization. We estimated the average marginal effect of treatment engagement in OAT or detoxification adjusting for potential fixed and time-varying confounders, including drug use and criminal justice system involvement prior to treatment initiation.
findingsDaily costs of crime during treatment compared with after treatment were $126 lower for OAT [95% confidence interval (CI) = $116, $136] and $144 lower for detoxification (95% CI = $135, $154). Summing the costs of crime during and after treatment over a hypothetical 6-month period using the observed median durations of OAT (161 days) and detoxification (19 days), we estimated that enrolling an individual in OAT as opposed to detoxification would save $17 550 ($16 840, $18 383).
conclusionsIn publicly funded drug treatment facilities in California, USA, engagement in treatment for opioid use disorders is associated with lower costs of crime in the 6 months following initiation of treatment, and the economic benefits were far greater for individuals receiving time-unlimited treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.